Polyclonal multiply antibiotic-resistant methicillin-resistant Staphylococcus aureus with Panton-Valentine leucocidin in England
Open Access
- 3 November 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 65 (1) , 46-50
Abstract
Community-associated methicillin-resistant Staphylococcus aureus (MRSA) including those encoding Panton-Valentine leucocidin (PVL) are often described as more susceptible to a range of antibiotics than their hospital-associated counterparts. Recent scattered reports of the emergence of multiresistant PVL-MRSA have highlighted the potential for resistance to emerge. Here we detail polyclonal multiply antibiotic-resistant PVL-MRSA occurring in England. PVL-MRSA from community-based and hospitalized patients located across England were identified by PCR. Isolates were characterized via MIC determinations, toxin gene profiling, PFGE, SCCmec, spa and agr typing. Multilocus sequence typing (MLST) was performed on selected isolates. Patient demographic and available disease data were retained for analysis. Seventy-six PVL-MRSA isolates resistant to three further classes of antibiotic were identified between 2005 and 2008 from centres in each of the Health Protection Agency's geographic regions in England. Patient demographics were typical for PVL-MRSA, and some travel associations were identified along with clonal spread. One instance of familial transmission in the community was detected. PVL-MRSA belonging to MLST clonal complex (CC) 1 (sequence type 772) were consistently highly resistant; multiply antibiotic-resistant representatives of CCs 5, 8, 22, 59 and 80 were also identified. Ciprofloxacin resistance was common amongst the study isolates (51 of 76 isolates). Genetically diverse multiply antibiotic-resistant PVL-MRSA were identified, and included representatives of a recently emerged multiresistant clone (dubbed the Bengal Bay clone). Risk factors and disease presentations were typical for PVL-MRSA infections. This work highlights the diminishing utility of ciprofloxacin susceptibility for putative identification of PVL-MRSA.Keywords
This publication has 9 references indexed in Scilit:
- Clinical and molecular epidemiology of ciprofloxacin-susceptible MRSA encoding PVL in England and WalesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- Prevalence of Panton–Valentine leukocidin genes among carriage and invasive Staphylococcus aureus isolates in MalaysiaInternational Journal of Infectious Diseases, 2009
- Genetic Characterization of Staphylococcus aureus Isolates Carrying Panton-Valentine Leukocidin Genes in BangladeshJapanese Journal of Infectious Diseases, 2008
- Molecular Epidemiology of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Isolates from Global Clinical TrialsJournal of Clinical Microbiology, 2008
- Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogensInternational Journal of Medical Microbiology, 2008
- Novel Characteristics of Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains Belonging to Multilocus Sequence Type 59 in TaiwanAntimicrobial Agents and Chemotherapy, 2008
- Emergence of Multidrug-Resistant, Community-Associated, Methicillin-Resistant Staphylococcus aureus Clone USA300 in Men Who Have Sex with MenAnnals of Internal Medicine, 2008
- Diagnosis and treatment of Panton–Valentine leukocidin (PVL)-associated staphylococcal pneumoniaInternational Journal of Antimicrobial Agents, 2007
- Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infectionsAmerican Journal of Infection Control, 2005